Compare CRNX & FITBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRNX | FITBO |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | 18616 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | N/A |
| IPO Year | 2018 | N/A |
| Metric | CRNX | FITBO |
|---|---|---|
| Price | $49.41 | $19.42 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $71.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | N/A |
| Earning Date | 11-06-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,535,000.00 | N/A |
| Revenue This Year | $425.31 | N/A |
| Revenue Next Year | $943.50 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 47.74 | N/A |
| 52 Week Low | $24.10 | N/A |
| 52 Week High | $60.25 | N/A |
| Indicator | CRNX | FITBO |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 37.52 |
| Support Level | $46.49 | $19.20 |
| Resistance Level | $50.98 | $19.58 |
| Average True Range (ATR) | 1.90 | 0.20 |
| MACD | 0.28 | 0.02 |
| Stochastic Oscillator | 75.65 | 30.29 |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.